Skip to main content
OpenTrials
Completed

NCT Number: NCT04518254

Contribution of L-Tyrosine to Human Decision Making in Stressful Situations

L-tyrosine is a chemical precursor of dopamine. Under specific conditions, tyrosine administration can increase brain dopamine levels and therefore several studies have explored whether tyrosine supplementation can have a beneficial effect on cognitive and behavioural performance that is dependent on dopaminergic function. However, the effects of tyrosine supplementation are mixed: some studies show positive effects while others do not. Stress leads to an increase in dopaminergic activity and turnover in the brain, resulting in a decrease in brain dopamine levels. We propose to study the contribution of tyrosine to decision making and more particularly to the processes of response selection (mediated by the prefrontal cortex and under the influence of the dopaminergic system) in stressful situations.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Institut de Recherche Biomédicale des Armées

Brétigny-sur-Orge, 91223, France

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • From 18 to 65 years of age

Exclusion criteria

  • Tyrosine intake within the previous 15 days
  • History of neurological or psychiatric disorder
  • History of nephrological or endocrine disorder or liver failure
  • Hereditary tyrosinemia

Treatment and study plan

Blood collection

Biological

A blood sample will be collected before and after treatment administration

L-Tyrosine 500 Mg

Drug

The participants will be administered 4 capsules of L-Tyrosine 500 mg per oral route

Placebo

Drug

The participants will be administered 4 capsules of Lactose 500 mg (placebo) per oral route

Cognitive tasks

Behavioral

The participants will perform cognitive decision-making tasks: Simon task and masking task after treatment administration

Stress exposure

Other

Unpleasant but not painful skin stimulations will be administered to the participants at variable intervals on the left leg during the cognitive tasks

Anxiety scale

Behavioral

Spielberger's State Trait Anxiety Inventory (STAI) will be filled by the participants before and after cognitive tasks

Electromyography (EMG)

Device

Electromyography measurements will be performed during cognitive tasks.

Electroencephalography (EEG)

Device

Electroencephalography measurements will be performed during cognitive tasks.

Primary outcomes

  1. Reaction Time

    Time frame: At day 9 (9 days after enrollment)

    Reaction Time at the cognitive tasks

  2. Number of incorrect responses

    Time frame: At day 9

    Number of incorrect responses at the cognitive tasks

Secondary outcomes

  1. Error negativity

    Time frame: At day 9

    Error negativity on motor evoked potentials (measured by EMG)

  2. Correlation coefficient between anxiety level and tyrosinemia

    Time frame: At day 9

    Correlation coefficient between anxiety level (measured by anxiety scale) and tyrosinemia (measured in blood sample)

  3. Correlation coefficient between anxiety level and plasma tyrosine

    Time frame: At day 9

    Correlation coefficient between anxiety level (measured by anxiety scale) and plasma tyrosine (measured in blood sample)

  4. Correlation coefficient between cortisolaemia and melatoninaemia

    Time frame: At day 9

    Correlation coefficient between cortisolaemia and melatoninaemia (measured in blood sample)

Sponsors and collaborators

Lead sponsor

Direction Centrale du Service de Santé des Armées

Other

Registry information

Acronym: TYRO-STRESS

Important dates

Study start
2021
Primary completion
2022
Study completion
2022
First posted
Aug 19, 2020
Registry last updated
Nov 25, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.